| Period | CPB | SPY | Delta |
|---|---|---|---|
| 3M | +2.8% | +11.4% | -8.6% |
| 6M | -25.7% | +8.2% | -33.9% |
| 1Y | -32.0% | +22.9% | -54.8% |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $10.25B+6.4% | $9.64B+3.0% | $9.36B+9.3% | $8.56B+1.0% | $8.48B |
| Cost of products sold | $7.13B+7.0% | $6.67B+3.5% | $6.44B+8.5% | $5.93B+4.8% | $5.67B |
| Marketing and selling expenses | $924.0M+10.9% | $833.0M+2.7% | $811.0M+10.5% | $734.0M-10.2% | $817.0M |
| Administrative expenses | $674.0M-8.5% | $737.0M+12.7% | $654.0M+6.0% | $617.0M+3.2% | $598.0M |
| Research and development expenses | $100.0M-2.0% | $102.0M+10.9% | $92.0M+5.7% | $87.0M+3.6% | $84.0M |
| Other expenses / (income) | $273.0M+4.6% | $261.0M+715.6% | $32.0M+52.4% | $21.0M+108.3% | -$254.0M |
| Restructuring charges | $24.0M-36.8% | $38.0M+137.5% | $16.0M+220.0% | $5.0M-76.2% | $21.0M |
| Total costs and expenses | $9.13B+5.7% | $8.64B+7.3% | $8.04B+8.7% | $7.40B+6.8% | $6.93B |
| Earnings before interest and taxes | $1.12B+12.4% | $1.00B-23.8% | $1.31B+12.8% | $1.16B-24.7% | $1.54B |
| Interest expense | $345.0M+38.6% | $249.0M+32.4% | $188.0M-0.5% | $189.0M-10.0% | $210.0M |
| Interest income | $17.0M+183.3% | $6.0M+50.0% | $4.0M+300.0% | $1.0M+0.0% | $1.0M |
| Earnings before taxes | $796.0M+5.2% | $757.0M-32.9% | $1.13B+15.7% | $975.0M-27.0% | $1.34B |
| Taxes on earnings | $194.0M+2.1% | $190.0M-29.6% | $270.0M+23.9% | $218.0M-33.5% | $328.0M |
| Net earnings | $602.0M+6.2% | $567.0M-33.9% | $858.0M+13.3% | $757.0M-24.5% | $1.00B |
| Less: Net earnings (loss) attributable to noncontrolling interests | $0 | $0 | $0 | $0 | $0 |
| Net earnings attributable to The Campbell's Company | $2.0M+6.3% | $1.9M-33.7% | $2.9M-99.6% | $757.0M-24.5% | $1.00B |
| Weighted average shares outstanding - basic | 298.0M+0.0% | 298.0M-0.3% | 299.0M-0.7% | 301.0M-0.7% | 303.0M |
| Weighted average shares outstanding - assuming dilution | 300.0M+0.0% | 300.0M-0.3% | 301.0M-0.3% | 302.0M-1.0% | 305.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Campbell's reported Q3 fiscal 2026 results with net sales down 4% to $2.4 billion and adjusted EPS down 32% to $0.50, reaffirming full-year guidance
“Our third quarter results were generally in-line with our expectations but remained under pressure, reflecting top-line softness and inflation-driven margin headwinds”
No Form 4 transactions on record.
Informational purposes only, not investment advice.